STOCK TITAN

Strategy director Jarrod M. Patten sells 950 shares

Of the 21,150 option shares remaining after the exercise, 8,650 vested in 2020 and 12,500 vested in 2021.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Strategy Inc director Jarrod M. Patten exercised 950 director stock options on November 3, 2026, acquiring 950 Class A common shares at an exercise price of $18.236 per share. He sold 950 Class A shares the same day at $136.04 per share. No Rule 10b5-1 plan is reported. After the exercise, 21,150 shares remained under the option, which expires May 31, 2027.

Insider Patten Jarrod M
Role Director
Sold 950 shs ($129K)
Approx. gross sale proceeds $129K
Approx. exercise cost $17K
Approx. pre-tax spread $112K
Share of Position Sold 3.2%
Type Security Shares Price Value
Exercise Director Stock Option (Right to buy) F1 950 $0.00 $0.00
Exercise Class A Common Stock 950 $18.236 $17K
Sale Class A Common Stock 950 $136.04 $129K
Holding Series A Perpetual Strife Preferred Stock -- -- --
Holding Series A Perpetual Stretch Preferred Stock -- -- --
Holding Series A Perpetual Stride Preferred Stock -- -- --
Holdings After Transaction: Director Stock Option (Right to buy) — 21,150 contracts (Direct); Class A Common Stock — 28,406 shares (Direct); Series A Perpetual Strife Preferred Stock — 10,000 shares (Direct); Series A Perpetual Stretch Preferred Stock — 29,335 shares (Direct); Series A Perpetual Stride Preferred Stock — 5,000 shares (Direct)
Holdings Before and After: Director Stock Option (Right to buy), 22,100 to 21,150 contracts (Direct); Class A Common Stock, 28,406 to 28,406 shares (Direct)
Footnotes (1)
  1. F1. The 950 shares exercised on November 3, 2026 pursuant to this option vested on May 31, 2020. Of the remaining 21,150 shares pursuant to this option, 8,650 vested on May 31, 2020, and 12,500 shares vested on May 31, 2021.
Director stock options exercised 950 options November 3, 2026
Exercise price $18.236 per share Options exercised November 3, 2026
Class A shares sold 950 shares November 3, 2026
Sale price $136.04 per share Sale on November 3, 2026
Shares remaining under option 21,150 shares After the November 3, 2026 exercise
Option expiration May 31, 2027 Director stock option
Director Stock Option financial
"950 shares exercised pursuant to this option"
exercise price financial
"at an exercise price of $18.236 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vested financial
"8,650 shares vested on May 31, 2020"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MSTR shares did director Jarrod M. Patten sell, and at what price?

Director Jarrod M. Patten sold 950 Class A common shares at $136.04 per share on November 3, 2026.

When did the remaining MSTR option shares vest?

Of the 21,150 shares remaining under the option after exercise, 8,650 vested on May 31, 2020, and 12,500 vested on May 31, 2021.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Patten Jarrod M

(Last)(First)(Middle)
C/O STRATEGY INC
1850 TOWERS CRESCENT PLAZA

(Street)
TYSONS CORNER VIRGINIA 22182

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Strategy Inc [ MSTR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/03/2026M950A$18.23629,356D
Class A Common Stock11/03/2026S950D$136.0428,406D
Series A Perpetual Strife Preferred Stock10,000D
Series A Perpetual Stretch Preferred Stock29,335D
Series A Perpetual Stride Preferred Stock5,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Director Stock Option (Right to buy)$18.23611/03/2026M950 (1)05/31/2027Class A Common Stock950$021,150D
Explanation of Responses:
1. The 950 shares exercised on November 3, 2026 pursuant to this option vested on May 31, 2020. Of the remaining 21,150 shares pursuant to this option, 8,650 vested on May 31, 2020, and 12,500 shares vested on May 31, 2021.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Allein Sabel, Attorney-in-Fact11/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading